Hot Topics in NASH: Current Controversies and New Developments in Fatty Liver Disease

Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk.

Brent A. Neuschwander-Tetri, MD Released: July 7, 2020

Hear Philip N. Newsome, PhD, FRCPE, discuss available approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance.

Philip N. Newsome, PhD, FRCPE Released: July 2, 2020

Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis.

Philip N. Newsome, PhD, FRCPE Released: July 1, 2020

Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests for NASH.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Released: July 7, 2020

What should our patients with NAFLD eat? Listen as expert hepatologist Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH.

Rotonya Carr, MD Released: July 8, 2020